The polysaccharide Pullulan improves the initial steps of allergen‐specific immunotherapy in dogs

Key Points

• This study aims to evaluate the effects of pullulan on allergen-specific immunotherapy in dogs with atopic dermatitis.
• Administered pullulan alongside allergen-specific immunotherapy (AIT)
• Assessed the efficacy of AIT in canine atopic dermatitis (CAD)
• Compared outcomes with and without pullulan to determine its impact
• Pullulan improved the efficacy of AIT in dogs with CAD
• Enhanced immune response noted in treated dogs
• Indicates pullulan's potential as an immunotherapeutic adjuvant independent of allergen source